Summary: Applied Curiosity Lab interviews MAPS Founder Rick Doblin, Ph.D., about his enduring goal of turning psychedelics and marijuana into prescription medicines.
Originally appearing here.
What are psychedelics? How could the world benefit from legalizing psychedelic drugs? What will it take for the FDA to approve prescription psychedelic drugs?
How is Rick Doblin and MAPS leading the charge to bring psychedelics into mainstream psychotherapy? How does MDMA save lives? What are you missing by not trying psychedelics? Are they dangerous?
Who is Rick Doblin?
Founder and Executive Director of Multidisciplinary Association for Psychedelic Studies (MAPS).
PhD in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients.
Conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment.
Student of Dr. Stanislav Grof and among the first to be certified as a Holotropic Breathwork practitioner.
Developer of legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines and for personal growth for otherwise healthy people.
What will you learn?
How to create the best psychedelic experience.
The mission of Multidisciplinary Association for Psychedelic Studies (MAPS) and how was created.
How MDMA assisted psychotherapy works and how it is different from classic psychoanalysis.
How MAPS obtained FDA approval for studying psychedelic drugs.
How a B-corp works, how this corporate structure works for MAPS, and how it could benefit other pharmaceutical companies.
How healing with psychedelics works.
How do you define psychedelics?
What does it mean to “go deep”?
Why do some people never recover from a psychedelic experience?
How important is reality?
How does one create a double-blind for drugs with such powerful effects?